News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
272,454 Results
Type
Article (17251)
Company Profile (35)
Press Release (255164)
Multimedia
Podcasts (19)
Webinars (5)
Section
Business (81508)
Career Advice (582)
Deals (14390)
Drug Delivery (25)
Drug Development (34223)
Employer Resources (40)
FDA (6185)
Job Trends (6263)
News (135171)
Policy (10288)
Tag
Academia (750)
Accelerated approval (5)
Adcomms (6)
Allergies (55)
Alliances (14500)
ALS (63)
Alzheimer's disease (582)
Antibody-drug conjugate (ADC) (100)
Approvals (6347)
Artificial intelligence (190)
Autoimmune disease (40)
Automation (12)
Bankruptcy (116)
Best Places to Work (4788)
BIOSECURE Act (2)
Biosimilars (76)
Biotechnology (24)
Bladder cancer (91)
Brain cancer (29)
Breast cancer (302)
Cancer (2117)
Cardiovascular disease (168)
Career advice (478)
Career pathing (7)
CAR-T (89)
CDC (4)
Cell therapy (279)
Cervical cancer (19)
Clinical research (30696)
Collaboration (630)
Company closure (2)
Compensation (450)
Complete response letters (8)
COVID-19 (937)
CRISPR (36)
C-suite (255)
Cystic fibrosis (60)
Data (2720)
Decentralized trials (1)
Denatured (4)
Depression (40)
Diabetes (192)
Diagnostics (2293)
Digital health (18)
Diversity (2)
Diversity, equity & inclusion (11)
Drug discovery (85)
Drug pricing (56)
Drug shortages (9)
Duchenne muscular dystrophy (92)
Earnings (50436)
Editorial (13)
Employer branding (7)
Employer resources (35)
Events (44578)
Executive appointments (469)
FDA (7531)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (594)
Gene editing (70)
Generative AI (12)
Gene therapy (219)
GLP-1 (447)
Government (1363)
Grass and pollen (4)
Guidances (319)
Healthcare (6635)
HIV (24)
Huntington's disease (13)
IgA nephropathy (35)
Immunology and inflammation (92)
Immuno-oncology (7)
Indications (32)
Infectious disease (1054)
Inflammatory bowel disease (76)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (82)
Interviews (112)
IPO (8015)
IRA (15)
Job creations (1760)
Job search strategy (411)
Kidney cancer (7)
Labor market (30)
Layoffs (187)
Leadership (3)
Legal (2179)
Liver cancer (41)
Longevity (3)
Lung cancer (343)
Lymphoma (139)
Machine learning (10)
Management (12)
Manufacturing (245)
MASH (72)
Medical device (4837)
Medtech (4847)
Mergers & acquisitions (6849)
Metabolic disorders (480)
Multiple sclerosis (78)
NASH (10)
Neurodegenerative disease (90)
Neuropsychiatric disorders (23)
Neuroscience (1058)
NextGen: Class of 2025 (2373)
Non-profit (1584)
Now hiring (11)
Obesity (213)
Opinion (69)
Ovarian cancer (72)
Pain (65)
Pancreatic cancer (76)
Parkinson's disease (117)
Partnered (10)
Patents (146)
Patient recruitment (152)
Peanut (20)
People (16346)
Pharmaceutical (8)
Pharmacy benefit managers (6)
Phase I (8436)
Phase II (13463)
Phase III (11441)
Pipeline (1905)
Policy (55)
Postmarket research (1071)
Preclinical (2842)
Press Release (44)
Prostate cancer (110)
Psychedelics (11)
Radiopharmaceuticals (88)
Rare diseases (270)
Real estate (2131)
Recruiting (14)
Regulatory (8143)
Reports (21)
Research institute (692)
Resumes & cover letters (117)
Rett syndrome (14)
RNA editing (5)
RSV (35)
Schizophrenia (62)
Series A (85)
Series B (74)
Service/supplier (5)
Sickle cell disease (31)
Special edition (9)
Spinal muscular atrophy (64)
Sponsored (13)
Startups (1237)
Stomach cancer (3)
Supply chain (45)
Tariffs (32)
The Weekly (15)
Vaccines (361)
Venture capital (18)
Weight loss (156)
Women's health (19)
Worklife (3)
Date
Today (62)
Last 7 days (339)
Last 30 days (1294)
Last 365 days (17086)
2025 (13677)
2024 (15103)
2023 (15017)
2022 (18874)
2021 (20133)
2020 (17970)
2019 (15532)
2018 (11807)
2017 (10742)
2016 (11550)
2015 (44339)
2014 (19409)
2013 (5929)
2012 (6496)
2011 (7322)
2010 (6287)
Location
Africa (369)
Alabama (25)
Alaska (3)
Arizona (73)
Arkansas (3)
Asia (16580)
Australia (2689)
California (4940)
Canada (1358)
China (396)
Colorado (194)
Connecticut (254)
Delaware (189)
Europe (40290)
Florida (590)
Georgia (127)
Hawaii (2)
Idaho (19)
Illinois (391)
India (24)
Indiana (255)
Iowa (9)
Japan (206)
Kansas (40)
Kentucky (13)
Louisiana (12)
Maine (32)
Maryland (546)
Massachusetts (3703)
Michigan (166)
Minnesota (234)
Mississippi (2)
Missouri (74)
Montana (11)
Nebraska (5)
Nevada (65)
New Hampshire (27)
New Jersey (1538)
New Mexico (5)
New York (1237)
North Carolina (562)
North Dakota (3)
Northern California (2281)
Ohio (117)
Oklahoma (7)
Oregon (15)
Pennsylvania (860)
Puerto Rico (3)
Rhode Island (9)
South America (471)
South Carolina (9)
Southern California (1879)
Tennessee (86)
Texas (781)
United States (17439)
Utah (135)
Virginia (111)
Washington D.C. (31)
Washington State (412)
West Virginia (3)
Wisconsin (67)
272,454 Results for "15".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Collaboration
Kite Makes $1.5B+ Cell Therapy Pact With Pregene as Others Pull Back
With more than $1.5 billion on the line, Gilead looks to bolster its CAR T portfolio.
October 17, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Rezolute to Participate in Upcoming Investor Conferences - October 15, 2025
October 16, 2025
·
1 min read
Press Releases
AlzeCure Pharma to Present at Redeye Neurology Day on October 15
October 8, 2025
·
2 min read
Antibody-drug conjugate (ADC)
Roche Inks Another China ADC Pact With $1.5B Hansoh Bet
Roche will gain worldwide rights outside of the Greater China region to Hansoh’s HS-20110, an antibody-drug conjugate in early-stage development for colorectal cancer.
October 17, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
BMS Makes $1.5B Cell Therapy Play With Orbital Takeover
Investor reaction to the deal was muted, with BMO Capital Markets analysts saying they “continue to look for more” from Bristol Myers Squibb before they can “get excited about the near term turnaround story.”
October 10, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Medtronic Announces Pricing of €1.5 Billion of Senior Notes
September 16, 2025
·
3 min read
Press Releases
Marble Raises $15.5M Series A to Scale Access to Youth Mental Health Care
October 15, 2025
·
3 min read
Press Releases
Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes
September 30, 2025
·
3 min read
Press Releases
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - October 15, 2025
October 16, 2025
·
1 min read
Layoffs
CSL Overhauls Business With Vaccine Spinout, 15% Layoffs
With its structural changes, CSL expects to generate $500 to $550 million in annualized savings over the next three years.
August 20, 2025
·
1 min read
·
Tristan Manalac
1 of 27,246
Next
